Evidence-Based Prescribing of Statins: A Developing World Perspective
Author Information
Author(s): H. T. Ong
Primary Institution: H. T. Ong Heart Clinic, Penang, Malaysia
Hypothesis
How should trial evidence on statins be applied to a resource-poor setting?
Conclusion
Statin therapy can be cost-effective for high-risk patients, but financial constraints in developing countries complicate its widespread use.
Supporting Evidence
- Statin therapy reduces coronary events in patients with or without prior cardiovascular disease.
- A meta-analysis involving 90,056 patients found that statin treatment reduces strokes and total mortality.
- Statins should be prescribed based on cardiovascular risk rather than solely on lipid levels.
- Ethnic differences in response to statins suggest that treatment may need to be tailored to specific populations.
- Statin therapy is cost-effective for high-risk patients, but affordability is a major issue in developing countries.
Takeaway
Statins help prevent heart problems, but they're really expensive, especially in poorer countries, so doctors need to be careful about who gets them.
Methodology
The paper reviews landmark clinical trials and meta-analyses to assess the effectiveness and cost-effectiveness of statins in various populations.
Potential Biases
Ethnic minorities were underrepresented in landmark trials, which may affect the applicability of findings.
Limitations
The trials primarily involved Western populations, which may not accurately represent responses in developing countries.
Participant Demographics
The study discusses various ethnic groups, including Asians and eastern Europeans, but does not provide specific demographics.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website